Form 8-K - Current report:
SEC Accession No. 0001193125-19-248388
Filing Date
2019-09-18
Accepted
2019-09-18 17:07:10
Documents
17
Period of Report
2019-09-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d806643d8k.htm   iXBRL 8-K 37500
2 EX-1.1 d806643dex11.htm EX-1.1 211674
3 EX-5.1 d806643dex51.htm EX-5.1 9063
4 EX-99.1 d806643dex991.htm EX-99.1 7241
5 EX-99.2 d806643dex992.htm EX-99.2 7708
9 GRAPHIC g806643g0918115426772.jpg GRAPHIC 2534
  Complete submission text file 0001193125-19-248388.txt   470496

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acad-20190917.xsd EX-101.SCH 3081
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20190917_lab.xml EX-101.LAB 18138
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20190917_pre.xml EX-101.PRE 11415
18 EXTRACTED XBRL INSTANCE DOCUMENT d806643d8k_htm.xml XML 3417
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 191100363
SIC: 2834 Pharmaceutical Preparations